Acute porphyria: сlinical cases from real practice
DOI: https://dx.doi.org/10.18565/therapy.2021.3.92-95
Cherepanova V.V.
Public Health Facility City Clinical Hospital No 33, Nizhny Novgorod
Abstract. Two clinical cases of acute porphyria are presented. Acute porphyria is a rare disease, a pathology associated with hereditary or acquired abnormalities of the biosynthesis of heme. The main features that distinguish these nosological forms are: the prevalence of precursors of porphyrins among laboratory-defined metabolites, rapid clinical progression of the disease; the absence of a correct diagnosis or late diagnosis result in life threateningneurological disorders. The main diagnostic difficulties are related to a non-specific character of clinical signs of acute intermittent porphyria, the clinical signsimitate a large range of somatic, including emergency, conditions. Despite the fact that porphyria belongs to orphan diseases, the polymorphism of the clinical picture, the difficulty of obtaining pathogenetic drugs in medical institutions for the treatment of this disease in Russia, familiarization with its clinical features is useful for a wide range of specialists.
Keywords: acute porphyria, difficulty of diagnosis, heme arginate
Literature
- Диагностика и лечение острых порфирий. Национальные клинические рекомендации. Национальное гематологическое общество. М., 2018. Доступ: https://npngo.ru/uploads/media_document/279/044fc924-3591-4898-b1df-0e11110bdb93.pdf (дата обращения – 10.03.2021). [Diagnosis and treatment of acute porphyrias. National clinical guideline. National Hematological Society. M. 2018. Available at: https://npngo.ru/uploads/media_document/279/044fc924-3591-4898-b1df-0e11110bdb93.pdf (date of access – 10.03.2021) (In Russ.)].
- Пустовойт Я.С., Галстян Г.М., Савченко В.Г. Диагностическая роль отдельных синдромов и симптомов в семиотике острых порфирий. Гематология и трансфузиология. 2014; 3: 35–38. [Pustovoyt Ya.S., Galstyan G.M., Savchenko V.G. Diagnostic role of separate syndromes and symptoms in acute porphyrias semeiotics. Gematologiya i transfuziologiya = Hematology and transfusiology. 2014; 3: 35–38 (In Russ.)].
- Загидуллина К.Л., Попова Н.А., Асташина Е.Е. Сложности диагностики острой перемежающейся порфирии в клинической практике. Казанский медицинский журнал. 2016; 6: 975–977. [Zagidullina K.L., Popova N.A., Astashina E.E. Difficulties in diagnosis of acute intermittent porphyria in clini-cal practice. Kazanskiy meditsinskiy zhurnal = Kazan medical journal. 2016; 6: 975–977 (In Russ.)]. doi: https://dx.doi.org/10.17750/KMJ2016-975.
- Абдрашитова Г.Т., Куликов А.Ю. Фармакоэкономический анализ применения лекарственного средства гемин в лечении пациентов с острой перемежающейся порфирией на территории Российской Федерации. Фармакоэкономика: теория и практика. 2016; 1: 165–168. [Abdrashitova G.T., Kulikov A.Yu. Pharmacoeconomic analysis of application of hemin pharmaceutical product in the treatment of patients with acute intermittent porphyria on the territory of the Russian Federation. Farmakoekonomika: teoriya i praktika = Pharmacoeconomics: Theory and practice. 2016; 1: 165–168 (In Russ.)].
About the Autors
Valentina V. Cherepanova, MD, consultant hematologist of Public Health Facility City Clinical Hospital No 33. Address: 603076, Nizhny Novgorod, 54 Lenin Avenue. Tel.: +7 (831) 258-12-87. E-mail: cherepanova.v@inbox.ru